Inhibition of the HDAC/Suv39/G9a pathway restores the expression of DNA damage-dependent major histocompatibility complex class I-related chain A and B in cancer cells

Immunotherapy is expected to be promising as a next generation cancer therapy. Immunoreceptors are often activated constitutively in cancer cells, however, such levels of ligand expression are not effectively recognized by the native immune system due to tumor microenvironmental adaptation. Studies...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncol Rep
Asıl Yazarlar: Nakajima, Nakako Izumi, Niimi, Atsuko, Isono, Mayu, Oike, Takahiro, Sato, Hiro, Nakano, Takashi, Shibata, Atsushi
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: D.A. Spandidos 2017
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5562072/
https://ncbi.nlm.nih.gov/pubmed/28677817
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/or.2017.5773
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller